Targeting Cell-Matrix Induced Chemoresistance With Regorafenib in a 3D Model of Osteosarcoma.

Saved in:
Bibliographic Details
Title: Targeting Cell-Matrix Induced Chemoresistance With Regorafenib in a 3D Model of Osteosarcoma.
Authors: Rao RR; Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle, Washington, USA.; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapies, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA., Huang MS; Department of Chemical Engineering, Stanford University, Stanford, California, USA., Zhang D; Department of Chemical Engineering, Stanford University, Stanford, California, USA., Huerta-López C; Department of Materials Science and Engineering, Stanford University, Stanford, California, USA., Long C; Department of Materials Science and Engineering, Stanford University, Stanford, California, USA., Rodriguez GA; Department of Materials Science and Engineering, Stanford University, Stanford, California, USA., Mozipo EAT; Department of Bioengineering, Stanford University, Stanford, California, USA., Sagi S; Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle, Washington, USA., Heilshorn SC; Department of Materials Science and Engineering, Stanford University, Stanford, California, USA.
Source: Journal of biomedical materials research. Part A [J Biomed Mater Res A] 2025 Sep; Vol. 113 (9), pp. e37985.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101234237 Publication Model: Print Cited Medium: Internet ISSN: 1552-4965 (Electronic) Linking ISSN: 15493296 NLM ISO Abbreviation: J Biomed Mater Res A Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1552-4965
DOI:10.1002/jbm.a.37985